Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05904210 · ClinicalTrials.gov registry record
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®
A clinical trial, sponsored by Laboratoire français de Fractionnement et de Biotechnologies.
- Completed
- Registry status
- 17
- Enrollment target
NCT05904210: Completed study, sponsored by Laboratoire français de Fractionnement et de Biotechnologies.
NCT05904210 is a clinical trial that has completed, run by Laboratoire français de Fractionnement et de Biotechnologies. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05904210 has completed, sponsored by Laboratoire français de Fractionnement et de Biotechnologies.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.
Primary Outcome
SEVENFACT® effectiveness will be evaluated based on the retrospective rating by the investigator using the Clinical Global Impression Efficacy Index (CGI-E) for each 'event' (bleeding episode, surgery or invasive procedure, or prophylaxis). Specifically, the proportion of patients receiving efficient treatment based on CGI-E will be estimated.
Interventions
- DRUG SEVENFACT®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2024-05-09 |
What the finished NCT05904210 record still lists
NCT05904210 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SEVENFACT® is the first listed.
NCT05904210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05904210 about?
NCT05904210 is a clinical study titled "Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®". Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to as...
What is the current status of trial NCT05904210?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2023-11-07. Estimated completion is 2024-05-09.
What interventions are being tested in trial NCT05904210?
The interventions under investigation include: SEVENFACT® (DRUG).
Who is sponsoring clinical trial NCT05904210?
This trial is sponsored by Laboratoire français de Fractionnement et de Biotechnologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI